Want to join the conversation?
Focus Diagnostics, the products business of $DGX, received FDA 501(k) clearance for its Simplexa Flu A/B & RSV Direct Kit. The kit can detect 46 additional influenza A/B strains and seven additional RSV strains. The approval increases the number of flu and RSV strains that Simplexa can detect to 92, the most for any FDA-cleared molecular test kit.
The latest earnings report by $VZ shows how it is losing customers despite offering the unlimited data plans, a record for the company.
$BEBE is closing down all its stores by the end of May.
$WFC agreed to hike its payout in a class-action settlement over unauthorized accounts by $32 million to $142 million for its retail sales practices. The settlement will now include customers who were impacted as early as May 2002.